A recent study published in Nature suggests that the shingles vaccine may lower the risk of dementia in older adults by 20% over seven years. Researchers found that the protective effect is more pronounced in women compared to men.
Shingles, or herpes zoster, is a viral infection that causes a painful rash. It results from the reactivation of the varicella-zoster virus—the same virus that causes chickenpox. Common symptoms include:
The virus remains dormant in nerve cells after a person recovers from chickenpox. As the immune system weakens with age, the virus can reactivate, leading to shingles.
The study, led by Stanford University’s School of Medicine, tracked over 280,000 Welsh adults. Researchers suggest that viruses affecting the nervous system, like shingles, may increase dementia risk. Their findings support the emerging theory that viral infections may play a role in cognitive decline.
Researchers analyzed health records and found that individuals who received the Zostavax vaccine (which was widely used before being phased out) were:
✅ 20% less likely to be diagnosed with dementia over the next seven years.
✅ More protected if they were women compared to men.
Dementia is a broad term describing cognitive decline that interferes with daily life, affecting memory, thinking, and reasoning. With no definitive cure, prevention is key. This study highlights a potential protective effect of the shingles vaccine, opening doors for future research on how vaccines may help prevent neurodegenerative diseases.
If you’re eligible for the shingles vaccine, discuss it with your doctor. Though Zostavax is no longer widely available, Shingrix is the newer and more effective alternative recommended for older adults. Taking preventive measures, such as vaccination, may contribute to long-term brain health.
This groundbreaking research suggests that vaccination against shingles may do more than just prevent a painful rash—it could help protect against dementia. As further studies explore the connection between viral infections and cognitive decline, vaccines could become a valuable tool in reducing dementia risk.
Discover actionable strategies to strengthen grassroots sports development in rural India. Insights from the Director… Read More
As trade tensions escalate, Indian pharmaceutical exports worth $10 billion face potential probe by the… Read More
Hindustan Unilever tells Delhi High Court it will withdraw Lakme's sunscreen ad targeting Derma Co.… Read More
Easter is not just about egg hunts and pastel colors—it’s also the perfect time to… Read More
Discover 5 actionable ways to live a more sustainable life, from cutting fast fashion to… Read More
India's obesity crisis is rising. Learn how cutting-edge weight loss drugs like Ozempic, Zepbound, and… Read More